Radiotherapy is an oncological mainstay. Targeted radiopharmaceuticals are sweeping the clinical landscape, but face substantial hurdles to realize their maximum potentials.
Long Live Radiopharmaceuticals!
Long Live Radiopharmaceuticals!
Long Live Radiopharmaceuticals!
Radiotherapy is an oncological mainstay. Targeted radiopharmaceuticals are sweeping the clinical landscape, but face substantial hurdles to realize their maximum potentials.